Benzinga | Nov 3, 2020 04:06PM EST

Five Prime Therapeutics Q3 EPS $(0.74) Misses $(0.60) Estimate

Five Prime Therapeutics (NASDAQ:FPRX) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.60) by 23.33 percent. This is a 28.16 percent increase over losses of $(1.03) per share from the same period last year.